###begin article-title 0
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 73 95 73 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 73 94 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 322 330 <span type="species:ncbi:9606">children</span>
Mannose binding lectin (MBL) has an important role in the activation of the complement system and opsonization of pathogenic microorganisms. Frequent polymorphisms found in the MBL2 gene affect the concentration and functionality of the protein and are associated with enhanced susceptibility to severe malaria in African children. Most MBL2 typing strategies were designed to the analysis of selected variants, the significance of whole haplotypes is poorly known. In this work, a new typing strategy was developed and validated in an association analysis of MBL2 with adult asymptomatic infection.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 252 274 252 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 252 273 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 483 487 <span type="species:ncbi:9319">Euro</span>
MBL2 allele-specific fragments of 144 healthy Gabonese adults were amplified by using haplotype-specific sequencing (HSS), a new strategy that combines sequence-specific PCR and sequence-based typing. The Gabonese were investigated for the presence of Plasmodium falciparum parasitaemia by the amplification of parasite genes, immunochromatographic antigen detection and microscopic analysis. HSS results were also compared with a previously used real-time PCR (RT-PCR) method in 72 Euro-Brazilians.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H, L</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X, Y</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P, Q</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, O</italic>
###xml 118 120 118 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C </italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 147 162 147 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*LYPA/LYPA </italic>
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*LYQC </italic>
###xml 278 284 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YA/YO </italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO/YO </italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 609 614 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
Fourteen polymorphisms were identified beside the commonly investigated promoter (H, L; X, Y; P, Q) and exon 1 (A, O; O = B, C or D) variants. The MBL2*LYPA/LYPA genotype was associated with the absence of asymptomatic infection (P = 0.017), whereas the MBL2*LYQC haplotype and YA/YO + YO/YO genotypes were associated with positive parasite counts in asymptomatic adults (P = 0.033 and 0.018, respectively). The associations were specific to LYPA (identical to the reference sequence Y16577) and LYQC (Y16578) and would not have been revealed by standard genotyping, as there was no association with LYPA and LYQC haplotypes carrying new polymorphisms defined by sequence-based typing. In contrast, HSS and RT-PCR produced very similar results in the less diverse European-derived population.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 133 147 133 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum-</italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 133 146 <span type="species:ncbi:5833">P. falciparum</span>
In this work, a new typing strategy for a highly polymorphic gene was developed and validated focusing on the asymptomatic status of P. falciparum-infected adults. In populations with high nucleotide diversity, it allowed for the identification of associations with fine-scaled haplotypes that would not have been found using common typing techniques. In this preliminary study, MBL2 haplotypes or SNPs linked to them were found associated with susceptibility to infection and parasitaemia control of asymptomatic adults.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 519 533 519 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 867 868 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 0 21 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 102 110 <span type="species:ncbi:9606">children</span>
###xml 172 177 <span type="species:ncbi:9606">child</span>
###xml 519 532 <span type="species:ncbi:5833">P. falciparum</span>
Plasmodium falciparum infection causes between one and two million deaths annually, mostly in African children less than 5 years of age. This means that every 30 seconds a child dies of malaria. Those who survive became increasingly immune to severe malaria with each disease episode [1]. Although the immune mechanisms in older individuals clear a large proportion of infected erythrocytes, part of the parasites can persist in the circulation without causing symptoms. Semi-immunity seems to be dependent on frequent P. falciparum reinfections and can be lost within a few weeks if the individual leaves the endemic area [2]. Frequent reinfections nevertheless are associated with anaemia, secondary bacterial infections and hyper-reactive malarial splenomegaly. Individuals with asymptomatic parasitaemia may also serve as a reservoir for transmissible parasites [3].
###end p 11
###begin p 12
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNF</italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOS2A</italic>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2</italic>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 377 378 377 378 <sc xmlns:xlink="http://www.w3.org/1999/xlink">D</sc>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 465 485 465 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schistosoma mansoni </italic>
###xml 489 503 489 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 465 484 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 489 502 <span type="species:ncbi:5833">P. falciparum</span>
Several genetic polymorphisms that modulate immune response were found to be associated with protection against malaria. They include alleles of the HLA system [4], of tumour necrosis factor (TNF) (for a review, see [5]), nitric oxide synthase 2 (NOS2A) [6] and mannose-binding lectin (MBL2) [7,8]. Mannose-binding lectin recognizes sugar moieties such as mannose and N-acetyl-D-glucosamine on a wide range of different microorganisms [9], and on parasites such as Schistosoma mansoni and P. falciparum [10,11]. Upon binding, it activates the complement system via interaction with MBL-associated serine proteases (MASP-1, -2, -3 and Map19) and kills the potential pathogen by the membrane-attack complex or by complement-mediated phagocytosis through increased deposition of opsonic C3 fragments. MBL is also able to directly opsonize the microorganism for phagocytosis and to modulate the release of pro-inflammatory cytokines.
###end p 12
###begin p 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 273 280 273 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*D </italic>
###xml 281 289 281 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arg52Cys</italic>
###xml 292 294 292 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B </italic>
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gly54Asp</italic>
###xml 309 311 309 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C </italic>
###xml 312 320 312 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gly57Glu</italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 607 608 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 720 730 720 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*H, L </italic>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X, Y </italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P, Q </italic>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1061 1071 1061 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*HYPA </italic>
###xml 1073 1078 1073 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 1080 1085 1080 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 1087 1092 1087 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXPA </italic>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYPD </italic>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPB </italic>
###xml 1109 1114 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 1116 1121 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPD </italic>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1181 1185 1181 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X/Y </italic>
###xml 1189 1193 1189 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/O </italic>
###xml 1210 1214 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYPA</italic>
###xml 1216 1221 1216 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 1225 1230 1225 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 1282 1284 1282 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YA</italic>
###xml 1300 1305 1300 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXPA </italic>
###xml 1321 1323 1321 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XA</italic>
###xml 1329 1333 1329 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYPD</italic>
###xml 1335 1339 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPB</italic>
###xml 1341 1346 1341 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 1350 1355 1350 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPD </italic>
###xml 1359 1361 1359 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO</italic>
###xml 1639 1644 1639 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 1648 1652 1648 1652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA</italic>
###xml 1712 1713 1712 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 496 501 <span type="species:ncbi:9606">human</span>
###xml 1410 1415 <span type="species:ncbi:71765">hitch</span>
MBL2 deficiency is associated with the susceptibility and severity of many diseases, as well as with protection against intracellular infections as tuberculosis, leprosy and leishmaniasis [12-14]. Three single nucleotide polymorphisms (SNPs) in the first exon of the gene: MBL2*D (Arg52Cys), B (Gly54Asp) and C (Gly57Glu) [15,16] are mainly responsible for the reduction of circulating levels of MBL oligomers and of functional activity of the protein, which is very common and widespread in the human species. They have been collectively labeled O, whereas the major alleles at these loci have been called A. The concentration of the protein in serum is further modulated by at least three SNPs in the promoter region: MBL2*H, L (located 550 bp before the transcription start site), X, Y (located 221 bp before the transcription start site) and P, Q (not coding SNP located 4 bp after the transcription start site) [17,18]. Linkage disequilibrium between the SNPs is responsible for eight haplotypes associated with increasingly lower MBL serum concentration: MBL2*HYPA = LYQA = LYPA > LXPA >> HYPD = LYPB = LYQC = LYPD [7]. Due to the strong concentration-lowering effect of the X/Y and A/O exon 1 variants, HYPA, LYQA and LYPA are commonly evaluated as a joined diplotype group "YA". Accordingly, LXPA is analyzed as "XA" and HYPD, LYPB, LYQC and LYPD as "YO". This approach nevertheless neglects important hitch-hiking effects that become evident with the analysis of complete haplotypes, as well as the functional effects of new SNPs. E.g. 14 additional allelic haplotypes were recently defined by this group, most of them similar to LYQA and LYPA, and one of them was found associated with severe malaria [7].
###end p 13
###begin p 14
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 268 282 268 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 268 281 <span type="species:ncbi:5833">P. falciparum</span>
This new MBL2 typing strategy for physical separation and sequencing analysis of promoter-exon 1 haplotypes, was validated by comparing it with real-time PCR (RT-PCR) in 72 Brazilian subjects of another study [19] and focusing for the first time on adult asymptomatic P. falciparum infection among 144 Gabonese individuals. The typing strategy was called haplotype-specific sequencing (HSS) and showed higher cost-benefit for physical separation of small-sized haplotypes if compared with cloning [20] and haplotype-specific extraction (HSE) methods [21]. It also allowed for the identification of associations with fine-scaled haplotypes that would not have been found using other typing techniques in an Afro-derived population.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects and samples
###end title 16
###begin p 17
###xml 119 133 119 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium spp</italic>
###xml 239 250 239 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. malariae</italic>
###xml 265 278 265 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 239 250 <span type="species:ncbi:5858">P. malariae</span>
###xml 265 278 <span type="species:ncbi:5833">P. falciparum</span>
###xml 358 362 <span type="species:ncbi:9319">Euro</span>
A total of 144 Gabonese adults that took part of a large epidemiologic survey to detect the prevalence of asymptomatic Plasmodium spp. infection in the villages around Lambarene, Gabon, were investigated. There were three individuals with P. malariae, negative for P. falciparum, in the original study [22]. They were not included in this study. Seventy-two Euro-Brazilians (Brazilians with major European ancestry), previously genotyped using RT-PCR with fluorescent hybridisation probes [19], were also genotyped with HSS to compare typing strategies. They were healthy blood donors resident in Parana state, South Brazil, sampled for different association studies. Ethical clearance was obtained from the ethics committee of the International Foundation Albert Schweitzer Hospital and from the local medical ethics committee in Brazil.
###end p 17
###begin title 18
Parasitaemia detection
###end title 18
###begin p 19
###xml 200 211 200 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium </italic>
###xml 223 227 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 328 334 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stevor</italic>
###xml 406 413 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">stevor </italic>
###xml 508 510 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 576 578 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
At least two experienced technicians independently counted the parasites in thick blood smears (TBS). They also performed a rapid diagnostic test (RDT) to detect markers for all four human pathogenic Plasmodium species (NOW(R) ICT Malaria Test; Binax, Inc., Portland, ME) and amplified subtelomeric variable open reading frame (stevor)genes to find submicroscopic parasitaemia by PCR. The amplification of stevor genes is highly sensitive, allowing the detection of as less as 10 parasites in 1 ml of blood [23]. Detailed description of the procedures is described elsewhere [22]. Although PCR is taken as the gold standard for detecting asymptomatic parasitaemia, sequestered parasites cannot be detected. Yet the RDT test relies on the detection of histidine-rich protein 2 (HRP-2), a protein secreted by the parasite. Due to the long half-life of HRP-2, a positive RDT result can also be interpreted as evidence for an infection cleared weeks before sampling. A positive RDT result was found for six of the PCR negative adults. Since there could have been a symptomatic parasitaemia in the recent past of these individuals, they were excluded from the non-parasitized group and not included in the asymptomatic group.
###end p 19
###begin p 20
###xml 536 538 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Thus the PCR negative group consisted of 62 individuals (mean age, 30 +/- 8 years [range, 18-49 years]) and the PCR positive asymptomatic group, of 76 individuals (mean age, 28 +/- 7 years [range, 18-47 years]). All individuals with a positive TBS result were PCR positive as well. Nevertheless 78% of asymptomatic parasitized individuals would not have been found using only the TBS test. The same could be stated for 45% of them using only the RDT test. These figures are in agreement with a larger study (78% and 48%, respectively) [22].
###end p 20
###begin title 21
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
MBL2 typing
###end title 21
###begin p 22
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H </italic>
###xml 566 568 566 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 619 621 619 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 674 676 674 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y </italic>
###xml 924 926 924 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 984 986 984 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q </italic>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Blood was collected with the anticoagulant ethylenediaminetetraacetic acid and DNA was extracted from peripheral blood mononuclear cells through standard salting-out and phenol/chloroform/isoamyl alcohol methods. A fragment of 1059 nucleotides was amplified using the forward primers MBLfor (5'-ATGGGGCTAGGCTGCTGAG-3') and the reverse primer MBLrev (5'-CCAACACGTACCTGGTTCCC-3'). Sequence specific (SSP) PCR products were generated using the same reverse primer, combined to forward primers specific for variant H (Hf: 5'-GCTTACCCAGGCAAGCCTGTG-3') or for the variant L (Lf: 5'-GCTTACCCAGGCAAGCCTGTC-3'); for the variant X (Xf: 5'-CCATTTGTTCTCACTGCCACC-3') or for the variant Y (Yf: 5'-CCATTTGTTCTCACTGCCACG-3'). The PCR product achieved with the primers Hf or Lf and MBLrev and Xf or Yf and MBLrev were 837 and 508 nucleotides in length, respectively. Hf and Lf were also combined to specific reverse primers for the variant P (Pr: 5'-CTCAGTTAATGAACACATATTTACCG-3') or for the variant Q (Qr: 5'-CTCAGTTAATGAACACATATTTACCA-3'), generating a product of 599 nucleotides. All fragments were sequenced with the amplification primers or with an internal exon 1 sequencing primer, MBLint (5'-GAGGCCAGGGATGGGTCATC-3'), using Big dye terminator version 1.1 chemistry (Applied Biosystems, Foster City, CA). Amplification conditions are described in detail elsewhere [24]. The reactions were purified with the Performa DTR V3 system (Edge BioSystems, Gaithersburg, MD) and analysed on an automated sequencer (ABI Prism 3100 Genetic Analyzer, Applied Biosystems, Foster City, CA). New variants (singletons) were verified by reamplification and resequencing.
###end p 22
###begin title 23
Statistical analyses
###end title 23
###begin p 24
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
Genotype and haplotype frequencies were obtained by direct counting. The haplotype frequency distributions found in this and in other studies [7,25] were compared by applying the exact test of population differentiation of Raymond and Rousset [26]. Deviations from Hardy-Weinberg equilibrium were tested using the approach described by Guo and Thompson [27]. These tests were performed using the software package ARLEQUIN version 3.1 [28]. Possible associations between MBL2 genotypes/alleles and susceptibility to asymptomatic infection were analysed with Fisher's exact tests.
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 287 296 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.388G&gt;A </italic>
###xml 304 311 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPAs1 </italic>
###xml 326 335 326 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.797C&gt;A </italic>
###xml 343 350 343 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQCs1 </italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H, L</italic>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X, Y</italic>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P, Q</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, O</italic>
###xml 491 493 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 498 500 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C </italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 67 71 <span type="species:ncbi:9319">Euro</span>
The same results were achieved using RT-PCR [19] and HSS in the 72 Euro-Brazilian samples, except for one individual, haplotyped as LYQA using real-time and as LYPA using this approach. Two heterozygote individuals also presented unexpected SNPs, which were only revealed by sequencing: g.388G>A (in the LYPAs1 haplotype) and g.797C>A (in the LYQCs1 haplotype). In the Gabonese, 14 polymorphisms were identified beside the commonly investigated promoter (H, L; X, Y; P, Q) and exon 1 (A, O; O = B, C or D) variants. In contrast to RT-PCR, HSS did not rely on maximum likelihood algorithms for haplotyping, but amplified and sequenced allelic fragments of heterozygote individuals in different tubes to determine the phase of all SNPs (Figure 1).
###end p 26
###begin p 27
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Haplotyping by PCR-SSP fragments sequencing</bold>
###xml 64 74 64 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA/LYQA </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 288 297 288 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.388G&gt;A </italic>
###xml 313 322 313 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.396A&gt;C </italic>
Haplotyping by PCR-SSP fragments sequencing. Results are from a LYPA/LYQA sample. Both chromosomes were coamplified with the Lf and the generic rev primer (rev270 from [7]), and separately amplified using Pr or Qr as reverse SSP primers. Vertical arrows in the electropherograms show the g.388G>A (rs7100749) and g.396A>C (rs11003124) SNPs. The approximate sites of the primers and of the sequences are represented by horizontal arrows and traced lines, respectively. In bold: SSP primers.
###end p 27
###begin p 28
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 357 370 357 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA-, LYQA- </italic>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 441 458 441 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H, L; X, Y; P, Q </italic>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, O </italic>
###xml 548 611 548 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPAs1, LYPAs2, LYPAs3, LYQAs1, LYQAs2, LYQCs1, LYQCs2, LYQCs3 </italic>
###xml 694 696 694 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 716 726 716 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*LYQC </italic>
###xml 926 931 926 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 210 218 <span type="species:ncbi:9606">children</span>
###xml 290 298 <span type="species:ncbi:9606">children</span>
MBL2 haplotypes identified in this study are listed [see Additional file 1]. The haplotype distribution of the Gabonese adults was homogeneous with those of the previously investigated Gabonese schoolchildren, children with uncomplicated malaria and with severe malaria [7] and of Ghanaian children [25]. On average, 38% of the Gabonese genotypes carried a LYPA-, LYQA- or LYQC haplotype presenting other SNPs than the commonly investigated H, L; X, Y; P, Q and A, O variants. They represent 20% of all haplotypes, which conventionally were called LYPAs1, LYPAs2, LYPAs3, LYQAs1, LYQAs2, LYQCs1, LYQCs2, LYQCs3 (s for "similar" to the mentioned haplotype). The haplotype with the most frequent O variant in Africa - MBL2*LYQC - was associated with a positive parasite count [14% or 17/124 in non-parasitized vs. 29% or 10/34 in TBS positive individuals, P = 0.033, O.R. = 2.62 (1.1-6.4)]. This association was specific to the LYQC haplotype (identical to the reference sequence Y16578).
###end p 28
###begin p 29
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 113 123 113 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA/LYPA </italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA-</italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X, Y </italic>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, O </italic>
###xml 577 611 577 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YA/YA, YA/XA, XA/XA, XA/YO, YA/YO </italic>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO/YO </italic>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 654 659 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 725 731 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO/YO </italic>
###xml 735 741 735 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YA/YO </italic>
Genotype frequencies from both Gabonese groups were at Hardy and Weinberg equilibrium (table 1). There were five LYPA/LYPA homozygotes in the adult non-parasitized group but none in the asymptomatic group (8% or 5/62 vs. 0% or 0/76, P = 0.017). This association was specific to LYPA (identical to the reference sequence Y16577): frequencies of all other genotypes with LYPA-similar haplotypes presented no significant differences. To look for the effect of X, Y and A, O variants, known to modulate the concentration of high-order MBL oligomers, the genotypes were grouped as: YA/YA, YA/XA, XA/XA, XA/YO, YA/YO and YO/YO (table 1). In agreement with the LYQC association, there was a significant increase in the frequency of YO/YO and YA/YO genotypes between parasite-free and asymptomatic parasitized adults having a positive TBS result [(27% or 17/62 vs. 59% or 10/17, P = 0.018, O.R. = 3.8 (1.2-11.5)].
###end p 29
###begin p 30
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
MBL2 genotype association with parasitaemia status
###end p 30
###begin p 31
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The median values for parasite counts are given, followed by the range in parentheses. Parasitaemia was calculated as parasites per microliter (counted parasites/no. of microscopic fields) x 600 [41]. The final result was obtained by calculating the arithmetic mean from parasite count of the first and second readings [22]. In bold: significant difference.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 432 446 432 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H/L, X/Y, P/Q </italic>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/B/C/D </italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYPA </italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYPD </italic>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LXPA </italic>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPB </italic>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 956 964 956 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.388G&gt;A</italic>
###xml 984 989 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA </italic>
###xml 1052 1057 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 1278 1283 1278 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1452 1457 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 1152 1156 <span type="species:ncbi:9319">Euro</span>
There are numerous published MBL2 genotyping techniques, based on restriction fragment length polymorphisms (RFLP) of PCR products [29], sequence-specific PCR [30,31], denaturing gradient gel electrophoresis of PCR-amplified fragments [32], real-time PCR with the hybridization of sequence-specific probes [19] and sequence-based typing [33]. Most of the earliest techniques are restricted to the identification of the conventional H/L, X/Y, P/Q and A/B/C/D variants and thus of the HYPA (reference sequence: Y16581), HYPD (Y16582), LXPA (Y16580), LYPA (Y16577), LYPB (Y16579), LYQA (Y16576) and LYQC (Y16578) haplotypes. Newer methods that allow the identification of other SNPs rely on maximum likelihood methods for phasing. It was established in previous work [7] that around 35% of all LYPA haplotypes in the Gabonese population are not identical with the reference sequence Y16577. These haplotypes carry additional variants, the most frequent being g.388G>A. Around 17% of the LYQA haplotypes are not identical with Y16576 and around 13% of the LYQC haplotypes are not identical with Y16578 in the same population. In contrast, only 1.4% of the Euro-Brazilian group presented uncommon SNPs. This is mainly due to the higher heterozygosity and nucleotide diversity of the MBL2 promoter region in African, compared to non-African populations [34]. In order not to lose information, it is recommended to use of a sequence-based typing technique in MBL2 disease association studies with Afro-derived populations.
###end p 33
###begin p 34
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
Phase knowledge also minimizes errors due to haplotyping algorithms. This could be achieved using cloning or haplotype-specific extraction (HSE). Both offer the possibility of isolating large fragments, even the whole homologue chromosomes of heterozygote individuals [20]. Cloning is nevertheless time-consuming and requires expertise with living cells and much more bench work than HSE, which relies on magnetic beads for haplotype separation [21]. After haplotype separation, HSE allows for amplification of genomic haplotype DNA, followed by further downstream applications. Small-sized haplotypes as those formed by the MBL2 promoter-exon1 SNPs and indels are more readily analyzed with HSS, which unifies physical separation, amplification and partial genotyping through SSP primers in the same reaction. HSS principles have also been applied to HLA genes before [35,36].
###end p 34
###begin p 35
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPD</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 199 201 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HYP </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HXPA </italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQB </italic>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
MBL2 physical haplotyping with SSP primers began in 2002 and led to the discovery of LYPD, a previously unrecognized MBL2 haplotype [30], and to the conclusion that the linkage disequilibrium of the D variant with the HYP promoter was not absolute, as formerly assumed. In contrast, other haplotypes whose existence was predicted by statistical algorithms have physically not been confirmed, including HXPA and LYQB [34].
###end p 35
###begin p 36
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 100 114 100 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 411 413 411 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 100 113 <span type="species:ncbi:5833">P. falciparum</span>
###xml 228 236 <span type="species:ncbi:9606">children</span>
###xml 295 303 <span type="species:ncbi:9606">children</span>
This work is the first MBL2 association study including only truly non-parasitized and asymptomatic P. falciparum infected adults. In contrast, other authors evaluated the association of O alleles with asymptomatic infection in children. The long-lasting asymptomatic status of infected African children depends on the number of previous malaria attacks [37]. This could explain why there was no association of O alleles with asymptomatic infection in a follow-up study with 158 Gabonese schoolchildren [38], but in a recent study with 480 Ghanaians, which included PCR-detected asymptomatic individuals [25]. A reason for absence of association in the first study could also be the inclusion of submicroscopically parasitized individuals as healthy controls, as well as false heterozygosity results because of incomplete digestion of the PCR product by the enzymes used in the MBL2 genotyping method [32].
###end p 36
###begin p 37
###xml 13 27 13 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 113 126 113 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sine qua non </italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 360 370 360 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA/LYPA </italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA-</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA </italic>
###xml 913 922 913 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-1165 G&gt;T</italic>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1204 1206 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 13 26 <span type="species:ncbi:5833">P. falciparum</span>
Asymptomatic P. falciparum infection is highly prevalent in the Gabonese adult population [22]. It seems to be a sine qua non condition for the maintenance of semi-immunity, which is lost within some weeks outside an endemic area [2]. It could nevertheless also lead to anaemia and other secondary complications. In this work, a significant association of the LYPA/LYPA genotype with protection against asymptomatic parasitaemia was found. None of the LYPA-similar haplotypes were associated with the infection, and so the association would not have been revealed by conventional MBL2 typing techniques. LYPA is probably an ancient haplotype, with a wide geographical distribution. It occurred in nine different African groups, being less common in East Asian and rare in Amerindian(-similar) populations [24,34]. In the Gabonese population, approximately half of the LYPA (Y16577) haplotypes carry a linked SNP (-1165 G>T), which could actually be responsible for the observed association. This SNP was only found in African populations [34]. It is less likely that the association is due to a 3' variant, since the 5' promoter-exon 1 region is separated from the 3' region by a recombination hot spot [39].
###end p 37
###begin p 38
###xml 37 47 37 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2*LYQC </italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO/YO </italic>
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YA/YO </italic>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YO/YO </italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC </italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/O </italic>
###xml 398 412 398 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 559 573 559 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. falciparum </italic>
###xml 782 791 782 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 795 803 795 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 198 206 <span type="species:ncbi:9606">children</span>
###xml 229 237 <span type="species:ncbi:9606">children</span>
###xml 398 411 <span type="species:ncbi:5833">P. falciparum</span>
###xml 502 510 <span type="species:ncbi:9606">children</span>
###xml 559 572 <span type="species:ncbi:5833">P. falciparum</span>
There was also an association of the MBL2*LYQC variant, YO/YO and YA/YO genotypes with microscopically detectable parasites. These preliminary findings in adults correlate well with some studies in children. In Ghanaian infected children, the YO/YO genotype was found to be associated with higher parasitaemia [40] and grouped LYQC haplotypesas well as A/O genotypes, with higher susceptibility to P. falciparum infection [25]. Despite some similarities between the associations found in adults and in children, the role of MBL in the immune response against P. falciparum may also change with the acquisition of semi immunity as individuals grow older, depending on the frequency of disease episodes. The replication of the results in a larger adult setting, as well as functional in vitro and in vivo studies, would help to clarify this suggestion.
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
HSS was validated as a fast and highly informative method for analyzing small-sized haplotypes of polymorphic genes in populations with high nucleotide diversity, as are the vast majority of Afro-derived ethnic groups. It is more affordable than HSE, which relies on magnetic beads, and as cloning, which requires living cells. In this preliminary study, MBL2 haplotypes or SNPs linked to them were associated with the susceptibility to infection and with parasitaemia control of asymptomatic adults.
###end p 40
###begin title 41
Competing interests
###end title 41
###begin p 42
The authors declare that they have no competing interests.
###end p 42
###begin title 43
Authors' contributions
###end title 43
###begin p 44
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 217 221 <span type="species:ncbi:9319">Euro</span>
ABWB developed the HSS method, performed the MBL2 genotyping and statistical analysis, and drafted the manuscript. IJM-R helped in interpretation of the data and to draft the manuscript. MLAP, SI and BL collected the Euro-Brazilian and Gabonese samples, respectively. PGK participated in the design of the study and revised the manuscript for important intellectual content. JFJK coordinated the study, participated in the statistical analysis and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 44
###begin title 45
Supplementary Material
###end title 45
###begin title 46
Additional file 1
###end title 46
###begin p 47
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MBL2 </italic>
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>MBL2 </italic>nucleotide changes and haplotype frequencies in the Gabonese samples according to parasitaemia status</bold>
###xml 411 426 411 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPAs1, LYPAs2 </italic>
###xml 430 436 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPAs3</italic>
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYPA</italic>
###xml 462 469 462 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQAs1 </italic>
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQAs2</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQA-</italic>
###xml 506 521 506 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQCs1, LYQCs2 </italic>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQCs3</italic>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LYQC</italic>
###xml 773 782 773 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.273G&gt;C </italic>
###xml 797 806 797 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.388G&gt;A </italic>
###xml 820 829 820 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.396A&gt;C </italic>
###xml 844 853 844 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.456G&gt;T </italic>
###xml 868 877 868 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.474A&gt;G </italic>
###xml 891 900 891 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.478G&gt;A </italic>
###xml 916 925 916 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.482A&gt;G </italic>
###xml 941 950 941 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.487A&gt;G </italic>
###xml 965 980 965 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.495delAAAGAG </italic>
###xml 995 1004 995 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.578G&gt;A </italic>
###xml 1019 1028 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.602G&gt;C </italic>
###xml 1042 1051 1042 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.659C&gt;T </italic>
###xml 1067 1076 1067 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.712A&gt;T </italic>
###xml 1092 1101 1092 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.753C&gt;T </italic>
###xml 1116 1125 1116 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.797C&gt;A </italic>
###xml 1140 1149 1140 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.826C&gt;T </italic>
###xml 1163 1172 1163 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.925C&gt;G </italic>
###xml 1188 1197 1188 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.926T&gt;G </italic>
###xml 1213 1223 1213 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.1052G&gt;A </italic>
###xml 1237 1247 1237 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g.1061G&gt;A </italic>
MBL2 nucleotide changes and haplotype frequencies in the Gabonese samples according to parasitaemia status. The data show the haplotype frequency in Gabonese individuals with and without detected parasites. The positions corresponding to the SNPs and to the deletion (position of the first deleted nucleotide) are shown in the first row (Reference sequence: Y16577). In bold: significant different frequencies. LYPAs1, LYPAs2 and LYPAs3:LYPA-similar haplotypes; LYQAs1 and LYQAs2: LYQA-similar haplotypes; LYQCs1, LYQCs2 and LYQCs3:LYQC-similar haplotypes. PCR polymerase chain reaction, TBS thick blood smear, - negative result, + positive result positive result, N number of chromosomes. All PCR-individuals were also negative in a Rapid Diagnosis Test. In SNP database: g.273G>C as rs11003125, g.388G>A as rs7100749, g.396A>C as rs11003124, g.456G>T as rs35615810, g.474A>G as rs7084554, g.478G>A as ss107796301, g.482A>G as ss107796302, g.487A>G as rs36014597, g.495delAAAGAG as rs10556764, g.578G>A as rs35236971, g.602G>C as rs7096206, g.659C>T as ss107796304, g.712A>T as ss107796305, g.753C>T as rs11003123, g.797C>A as rs45602536, g.826C>T as rs7095891, g.925C>G as ss107796306, g.926T>G as ss107796307, g.1052G>A as rs1800450, g.1061G>A as rs1800451. All ss numbers were submitted by the authors to the SNP database and will be changed to rs numbers in the near future.
###end p 47
###begin p 48
Click here for file
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
The subjects of this investigation were informed about the aims of the study and their consent to participate is gratefully acknowledged. We thank Andrea Weierich and Silvelia Grummes for excellent technical assistance. Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
###end p 50
###begin article-title 51
Immunity to non-cerebral severe malaria is acquired after one or two infections
###end article-title 51
###begin article-title 52
###xml 88 96 <span type="species:ncbi:9606">children</span>
Observations on the early course of untreated falciparum malaria in semi-immune African children following a short period of protection
###end article-title 52
###begin article-title 53
Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon
###end article-title 53
###begin article-title 54
Common west African HLA antigens are associated with protection from severe malaria
###end article-title 54
###begin article-title 55
Cerebral malaria and immunogenetics
###end article-title 55
###begin article-title 56
Polymorphism in the promoter region of the inducible nitric oxide synthase gene and protection against malaria
###end article-title 56
###begin article-title 57
###xml 84 92 <span type="species:ncbi:9606">children</span>
Association of a new mannose-binding lectin variant with severe malaria in Gabonese children
###end article-title 57
###begin article-title 58
###xml 63 85 63 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum </italic>
###xml 63 84 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria
###end article-title 58
###begin article-title 59
Anti-microbial activities of mannose-binding lectin
###end article-title 59
###begin article-title 60
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schistosoma mansoni</italic>
###xml 0 19 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Schistosoma mansoni: Adhesion of mannan-binding lectin to surface glycoproteins of cercariae and adult worms
###end article-title 60
###begin article-title 61
###xml 15 36 <span type="species:ncbi:5833">plasmodium falciparum</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
Recognition of plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system
###end article-title 61
###begin article-title 62
Genotypes of the Mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications
###end article-title 62
###begin article-title 63
Dual role of mannan-binding protein in infections: another case of heterosis?
###end article-title 63
###begin article-title 64
The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm
###end article-title 64
###begin article-title 65
Mannose-binding lectin deficiency - revisited
###end article-title 65
###begin article-title 66
###xml 32 37 <span type="species:ncbi:9606">human</span>
Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein
###end article-title 66
###begin article-title 67
###xml 25 30 <span type="species:ncbi:9606">human</span>
Promoter variants of the human mannose-binding lectin gene show different binding
###end article-title 67
###begin article-title 68
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
###end article-title 68
###begin article-title 69
Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes
###end article-title 69
###begin article-title 70
###xml 24 29 <span type="species:ncbi:9606">human</span>
Haplotype sorting using human fosmid clone end-sequence pairs
###end article-title 70
###begin article-title 71
Haplotype-specific extraction: a universal method to resolve ambiguous genotypes and detect new alleles - demonstrated on HLA-B
###end article-title 71
###begin article-title 72
###xml 32 53 <span type="species:ncbi:5833">Plasmodium falciparum</span>
High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults
###end article-title 72
###begin article-title 73
###xml 15 36 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines
###end article-title 73
###begin article-title 74
Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus
###end article-title 74
###begin article-title 75
###xml 79 87 <span type="species:ncbi:9606">children</span>
Mannose-binding lectin variant associated with severe malaria in young African children
###end article-title 75
###begin article-title 76
An exact test for population differentiation
###end article-title 76
###begin article-title 77
Performing the exact test of Hardy-Weinberg proportion for multiple alleles
###end article-title 77
###begin article-title 78
Arlequin ver. 3.0: An integrated software ackage for population genetics data analysis
###end article-title 78
###begin article-title 79
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America
###end article-title 79
###begin article-title 80
A new strategy for mannose-binding lectin gene haplotyping
###end article-title 80
###begin article-title 81
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers
###end article-title 81
###begin article-title 82
###xml 54 59 <span type="species:ncbi:9606">human</span>
Genotyping of the three major allelic variants of the human mannose-binding lectin gene by denaturing gradient gel electrophoresis
###end article-title 82
###begin article-title 83
Detection of three single nucleotide polymorphisms in the gene encoding mannose-binding lectin in a single pyrosequencing reaction
###end article-title 83
###begin article-title 84
Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles
###end article-title 84
###begin article-title 85
B*4440: a novel HLA-B allele identified by sequence-specific oligonucleotide hybridization and sequence-specific amplification
###end article-title 85
###begin article-title 86
Description of a novel HLA-B allele, B*5613, identified during HLA-typing using sequence-specific oligonucleotide hybridization and sequence-specific amplification
###end article-title 86
###begin article-title 87
###xml 62 83 <span type="species:ncbi:5833">Plasmodium falciparum</span>
A novel semi-automatic image processing approach to determine Plasmodium falciparum parasitemia in Giemsa-stained thin blood smears
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 45 66 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren
###end article-title 88
###begin article-title 89
Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection
###end article-title 89
###begin article-title 90
###xml 97 118 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes
###end article-title 90
###begin article-title 91
###xml 61 69 <span type="species:ncbi:9606">children</span>
Comparison of methods for the rapid laboratory assessment of children with malaria
###end article-title 91

